E-Learning

3 Reasons to Sell PBI and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Pitney Bowes has surged ahead as its stock price has climbed by 39.6% to $9.27 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Read more

3 Reasons IART is Risky and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This performance may have investors wondering how to approach the situation.

Read more

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Read more